The optimal timing of immunotherapy may improve pregnancy outcome in women with unexplained recurrent pregnancy loss: A perspective follow‐up study in northeastern China-Reference-Cited by-同舟云学术

The optimal timing of immunotherapy may improve pregnancy outcome in women with unexplained recurrent pregnancy loss: A perspective follow‐up study in northeastern China

Published:2020-02-07 Issue:4 Volume:83 Page:
ISSN:1046-7408
Container-title:American Journal of Reproductive Immunology
language:en
Short-container-title:Am J Reprod Immunol

Author:

Hou Yue¹²,Li Jiapo¹²,Liu Qian¹²,Zhang Liyang¹²,Chen Bingnan¹²,Li Yuanyuan¹²,Bian Yue¹²,Huang Ling¹²,Qiao Chong¹²^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology Shengjing Hospital of China Medical University Shenyang China

2. Key Laboratory of Maternal‐Fetal Medicine China Medical University Shenyang China

Publisher

Wiley

Subject

Obstetrics and Gynecology,Reproductive Medicine,Immunology,Immunology and Allergy,Obstetrics and Gynecology,Immunology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aji.13225

Reference30 articles.

1. Revised guidelines for good practice in IVF laboratories (2015)

2. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial

3. Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage

4. THE FETUS AS AN ALLOGRAFT: EVIDENCE FOR PROTECTIVE ANTIBODIES TO HLA-LINKED PATERNAL ANTIGENS

5. Allogenic Lymphocyte Immunotherapy for Unexplained Recurrent Spontaneous Abortion: A Meta-Analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific plasma microRNA profiles could be potential non-invasive biomarkers for biochemical pregnancy loss following embryo transfer;BMC Pregnancy and Childbirth;2024-05-08

2. Clinical phenotype, treatment strategy and pregnancy outcome of non‐criteria obstetric antiphospholipid syndrome;American Journal of Reproductive Immunology;2023-03-09

3. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss;Journal of Korean Medical Science;2022

4. Effect of Prepregnancy Lymphocyte Active Immunotherapy on Unexplained Recurrent Miscarriage, Pregnancy Success Rate, and Maternal-Infant Outcome;BioMed Research International;2021-10-14

5. Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art;Journal of Clinical Medicine;2021-02-20